Autism Spectrum Disorder (ASD)
Introduction
Autism Spectrum Disorder (ASD), also known as autism, is a neurodevelopmental disorder characterized by core symptoms including social interaction impairments, communication difficulties, and restricted, repetitive patterns of behavior or interests, typically manifesting before the age of 3. Approximately two-thirds of children exhibit gradual onset during infancy, often accompanied by varying degrees of intellectual disability, sensory processing abnormalities, and other comorbidities. Early intervention during the critical window period is pivotal for improving long-term outcomes.
Why Choose China
Advanced Technologies
Multiple medical teams across China have pioneered fecal microbiota transplantation (FMT) therapy for autism spectrum disorder (ASD). Clinical trials demonstrate that FMT significantly alleviates severe gastrointestinal distress in autistic children – while concurrently improving core ASD symptoms such as social communication deficits and repetitive behaviors. This dual-targeted approach (gut-brain axis modulation) opens new horizons for autism intervention. Also, Chinese researchers have pioneered the development of Bacteroides fragilis BF839, a proprietary probiotic strain validated in randomized double-blind clinical trials for significantly alleviating behavioral abnormalities and gastrointestinal symptoms in children with ASD. This breakthrough complements traditional behavioral and pharmacological therapies, offering a safe, microbiome-targeted approach to symptom management. China’s unique neuroregulation-meridian therapy synergizes evidence-based behavioral interventions (e.g., ABA, TEACCH) with traditional Chinese medicine (TCM) such as Accupuncture, Tui Na massage.
Experienced Doctors
With 2 million diagnosed cases and over 100,000 new patients annually, Chinese clinicians have accumulated profound expertise in managing complex ASD presentations.
Autism Spectrum Disorder (ASD)
Introduction
Autism Spectrum Disorder (ASD), also known as autism, is a neurodevelopmental disorder characterized by core symptoms including social interaction impairments, communication difficulties, and restricted, repetitive patterns of behavior or interests, typically manifesting before the age of 3. Approximately two-thirds of children exhibit gradual onset during infancy, often accompanied by varying degrees of intellectual disability, sensory processing abnormalities, and other comorbidities. Early intervention during the critical window period is pivotal for improving long-term outcomes.
Why Choose China
Advanced Technologies
Multiple medical teams across China have pioneered fecal microbiota transplantation (FMT) therapy for autism spectrum disorder (ASD). Clinical trials demonstrate that FMT significantly alleviates severe gastrointestinal distress in autistic children – while concurrently improving core ASD symptoms such as social communication deficits and repetitive behaviors. This dual-targeted approach (gut-brain axis modulation) opens new horizons for autism intervention. Also, Chinese researchers have pioneered the development of Bacteroides fragilis BF839, a proprietary probiotic strain validated in randomized double-blind clinical trials for significantly alleviating behavioral abnormalities and gastrointestinal symptoms in children with ASD. This breakthrough complements traditional behavioral and pharmacological therapies, offering a safe, microbiome-targeted approach to symptom management. China’s unique neuroregulation-meridian therapy synergizes evidence-based behavioral interventions (e.g., ABA, TEACCH) with traditional Chinese medicine (TCM) such as Accupuncture, Tui Na massage.
Experienced Doctors
With 2 million diagnosed cases and over 100,000 new patients annually, Chinese clinicians have accumulated profound expertise in managing complex ASD presentations.